Indeed, plasma S100A8/S100A9 levels correlate with leukocyte counts and coronary artery disease in patients with type 1 diabetes,55 suggesting that targeting the S100A8/S100A9‐RAGE axis could reduce atherosclerosis progression and cardiovascular events in diabetic individuals with adequate glycemic control. This evidence concerns the gene S100A8 and atherosclerosis.